4527 Stock Overview
Manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Rohto Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,724.00 |
| 52 Week High | JP¥3,688.00 |
| 52 Week Low | JP¥2,638.00 |
| Beta | -0.20 |
| 1 Month Change | 0.22% |
| 3 Month Change | -22.24% |
| 1 Year Change | -3.28% |
| 3 Year Change | 57.46% |
| 5 Year Change | 62.63% |
| Change since IPO | 1,177.37% |
Recent News & Updates
Rohto PharmaceuticalLtd's (TSE:4527) Upcoming Dividend Will Be Larger Than Last Year's
Dec 06
Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 15Recent updates
Rohto PharmaceuticalLtd's (TSE:4527) Upcoming Dividend Will Be Larger Than Last Year's
Dec 06Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 15Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well
Oct 20Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price
Oct 06Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down
Sep 22Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors
Aug 25Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next
Aug 11Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?
Jul 11Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Jun 23Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares
Jun 10Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward
May 14These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely
Apr 03Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching
Mar 21Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year
Mar 07Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Feb 26Shareholder Returns
| 4527 | JP Personal Products | JP Market | |
|---|---|---|---|
| 7D | -0.3% | -2.8% | -1.9% |
| 1Y | -3.3% | -7.7% | 14.6% |
Return vs Industry: 4527 exceeded the JP Personal Products industry which returned -7.7% over the past year.
Return vs Market: 4527 underperformed the JP Market which returned 14.6% over the past year.
Price Volatility
| 4527 volatility | |
|---|---|
| 4527 Average Weekly Movement | 6.2% |
| Personal Products Industry Average Movement | 3.8% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4527's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 4527's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1899 | 7,259 | Yamada Kunio | www.rohto.co.jp |
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.
Rohto Pharmaceutical Co.,Ltd. Fundamentals Summary
| 4527 fundamental statistics | |
|---|---|
| Market cap | JP¥613.12b |
| Earnings (TTM) | JP¥27.26b |
| Revenue (TTM) | JP¥282.05b |
22.8x
P/E Ratio2.2x
P/S RatioIs 4527 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4527 income statement (TTM) | |
|---|---|
| Revenue | JP¥282.05b |
| Cost of Revenue | JP¥120.22b |
| Gross Profit | JP¥161.83b |
| Other Expenses | JP¥134.57b |
| Earnings | JP¥27.26b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | 119.50 |
| Gross Margin | 57.38% |
| Net Profit Margin | 9.67% |
| Debt/Equity Ratio | 16.8% |
How did 4527 perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield13%
Payout RatioDoes 4527 pay a reliable dividends?
See 4527 dividend history and benchmarks| Rohto PharmaceuticalLtd dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 13 2025 |
| Days until Ex dividend | 97 days |
| Days until Dividend pay date | 174 days |
Does 4527 pay a reliable dividends?
See 4527 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 14:53 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Rohto Pharmaceutical Co.,Ltd. is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mitsuko Miyasako | Barclays |
| Hidemaru Yamaguchi | Citigroup Global Markets Japan Inc. |
| Hidemaru Yamaguchi | Citigroup Inc |